The $6.8 Trillion Wellness Economy: How Big It Got and What Drives It
Global wellness spending now dwarfs the pharmaceutical industry. Here is where the money goes, what is fueling it, and where real health value parts from marketing.
Preventive and functional medicine, wearables, metabolic health and the wellness economy.
Global wellness spending now dwarfs the pharmaceutical industry. Here is where the money goes, what is fueling it, and where real health value parts from marketing.
Smart rings, watches and glucose patches now track heart rate variability, sleep, blood oxygen and glucose around the clock. Here is what the numbers can and cannot tell you, and who sees them.
The cardiovascular and metabolic evidence behind semaglutide and tirzepatide is strong and growing. The claim that these drugs slow aging is far less settled.
Both promise to catch disease early and treat root causes. One rests on decades of screening trials. The other is praised by some major hospitals and called a marketing term by its critics.